Search icon

ULTRAST INC.

Company Details

Name: ULTRAST INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 04 Mar 2011 (14 years ago)
Entity Number: 4063532
ZIP code: 11572
County: Nassau
Place of Formation: Delaware
Address: 3286 BALSAM STREET, OCEANSIDE, NY, United States, 11572
Principal Address: 3286 BALSAM ST, OCEANSIDE, NY, United States, 11572

Chief Executive Officer

Name Role Address
HOWARD LEVINE Chief Executive Officer 3286 BALSAM ST, OCEANSIDE, NY, United States, 11572

DOS Process Agent

Name Role Address
ULTRAST INC. DOS Process Agent 3286 BALSAM STREET, OCEANSIDE, NY, United States, 11572

History

Start date End date Type Value
2023-04-21 2023-04-21 Address 3286 BALSAM ST, OCEANSIDE, NY, 11572, USA (Type of address: Chief Executive Officer)
2021-03-03 2023-04-21 Address 3286 BALSAM STREET, OCEANSIDE, NY, 11572, USA (Type of address: Service of Process)
2020-03-11 2023-04-21 Address 3286 BALSAM ST, OCEANSIDE, NY, 11572, USA (Type of address: Chief Executive Officer)
2013-03-07 2020-03-11 Address 107 BALSAM ST, OCEANSIDE, NY, 11572, USA (Type of address: Chief Executive Officer)
2013-03-07 2020-03-11 Address 107 BALSAM ST, OCEANSIDE, NY, 11572, USA (Type of address: Principal Executive Office)

Filings

Filing Number Date Filed Type Effective Date
230421003509 2023-04-21 BIENNIAL STATEMENT 2023-03-01
210303061988 2021-03-03 BIENNIAL STATEMENT 2021-03-01
200311060330 2020-03-11 BIENNIAL STATEMENT 2019-03-01
130307002647 2013-03-07 BIENNIAL STATEMENT 2013-03-01
110304000923 2011-03-04 APPLICATION OF AUTHORITY 2011-03-04

Trademarks Section

Serial Number:
88469502
Mark:
ULTRAST
Status:
REGISTERED
Mark Type:
TRADEMARK
Application Filing Date:
2019-06-12
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
ULTRAST

Goods And Services

For:
viscous phase shifting formulations for use in connection with medical visualization procedures, namely, ultrasound, hysteroscopy, and hysterosalpingography; anti-adhesion formulations for use in preventing or reducing adhesions or scarring following surgery, and use for drug delivery
First Use:
2020-04-20
International Classes:
005 - Primary Class
Class Status:
Active

Date of last update: 27 Mar 2025

Sources: New York Secretary of State